Biohaven Pharmaceuticals, Inc FDA Record
Biohaven Pharmaceuticals, Inc has 0 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Biohaven Pharmaceuticals, Inc" is on file.
- Latest inspection
- Apr 24, 2025 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 3 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Biohaven Pharmaceuticals, Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Biohaven Pharmaceuticals, Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Apr 24, 2025 | New Haven, CT | Drugs | No Action Indicated (NAI) | 3010802167 |
| Sep 9, 2022 | New Haven, CT | Drugs | No Action Indicated (NAI) | 3010802167 |
| Nov 7, 2019 | New Haven, CT | Drugs | Voluntary Action Indicated (VAI) | 3010802167 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3010802167 | New Haven, CT | 3 | Apr 24, 2025 |
Biohaven Pharmaceuticals, Inc and the FDA: common questions
Has Biohaven Pharmaceuticals, Inc received an FDA warning letter?
No FDA warning letter addressed to the name "Biohaven Pharmaceuticals, Inc" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Biohaven Pharmaceuticals, Inc received an FDA Form 483?
FDA has not published a Form 483 for "Biohaven Pharmaceuticals, Inc" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Biohaven Pharmaceuticals, Inc?
The most recent FDA inspection on file ended Apr 24, 2025 at New Haven, CT and was classified NAI. FDA has 3 inspections of Biohaven Pharmaceuticals, Inc on file.
Need more than this page shows? Ask about Biohaven Pharmaceuticals, Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.